GAS5 and hepatocellular carcinoma: Knockout experiments targeting GAS5 or SMARCA4 and overexpression of miR-423-3p demonstrated reduced tumorigenesis, highlighting the oncogenic role of the GAS5–miR-423-3p–SMARCA4 axis in HCC progression.